Archives

Sponsored by Total Diversity Join us as we kick off the Diversity Site Solutions Summit!

The SCRS team and members of the site community will share insightful data about diversity in clinical trials as we set the tone for the rest of the Summit. This new survey will focus solely on diversity, equity, and inclusion in clinical trials and provide observations, awareness and understanding of site needs for more inclusive […]

The clinical research industry has spent significant time defining diversity, equity, and inclusion (DE&I) and discussing present needs for clinical trials. However, why do we truly need to focus on DE&I? What is the science behind why DE&I matters for the future of our medicines? This panel will discuss the scientific evidence driving the emphasis […]

Over the last several years, the FDA and other regulatory agencies have issued mandates, guidance, and laws regarding the need to increase diversity in clinical trial design. But what will these new requirements really entail for sites, sponsors and CROs? This group of experts will give insights into what the industry needs to know about […]

The SCRS Diversity Site Assessment Tool (DSAT) is quickly becoming an industry standard for understanding DE&I-related site capabilities, as well as a leading source of data for the industry on the needs of the site community. Come hear from the SCRS team and diversity working group members as they share how the tool is being […]

The patient perspective is a critical piece to the execution of clinical trials and incredibly valuable to help us remain focused on what we strive to do: bring medicines to patients faster. Hear from a panel of patients as they discuss their experiences with clinical trials from their unique and diverse backgrounds.

Technology is an essential and ever-increasing part of our clinical trial execution with the potential to make clinical trials more equitable and accessible. As the use of technology in trials grows, it’s imperative that we continue addressing the challenges the industry is facing with added technologies while finding solutions to enable increased diversity, equity, and […]

Individuals who represent diverse populations are essential advocates for advancing DE&I in our clinical trials, sharing a collective voice for their communities. Our panel will share perspectives from a variety of diverse communities and the needs of these populations in our trials and workforce.

Clinical trials often face challenges in recruiting a diverse group of participants, which can limit the generalizability of the results. This is particularly true in countries like Guatemala, where the clinical trial and healthcare landscape can present unique challenges. In this session, we will explore the importance of clinical trials and healthcare for the population […]